BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 16181206)

  • 1. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
    Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
    Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
    Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
    Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective molecular RHD typing strategy for blood donations.
    Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
    Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids.
    Chen Q; Hustinx H; Flegel WA
    Transfusion; 2006 May; 46(5):766-72. PubMed ID: 16686844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.
    Luettringhaus TA; Cho D; Ryang DW; Flegel WA
    Transfusion; 2006 Dec; 46(12):2128-37. PubMed ID: 17176325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RHCE alleles detected after weak and/or discrepant results in automated Rh blood grouping of blood donors in Northern Germany.
    Döscher A; Vogt C; Bittner R; Gerdes I; Petershofen EK; Wagner FF
    Transfusion; 2009 Sep; 49(9):1803-11. PubMed ID: 19453979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
    Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
    Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles.
    Silvy M; Simon S; Gouvitsos J; Di Cristofaro J; Ferrera V; Chiaroni J; Bailly P
    Transfusion; 2011 Feb; 51(2):401-11. PubMed ID: 20723165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between serology and genetics of weak D types in Denmark.
    Christiansen M; Samuelsen B; Christiansen L; Morbjerg T; Bredahl C; Grunnet N
    Transfusion; 2008 Jan; 48(1):187-93. PubMed ID: 17900277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes.
    Cruz BR; Chiba AK; Moritz E; Bordin JO
    Transfus Med; 2012 Apr; 22(2):84-9. PubMed ID: 22211984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.
    Lejon Crottet S; Haer-Wigman L; Gowland P; Fontana S; Niederhauser C; Hustinx H
    Transfusion; 2013 Nov; 53(11 Suppl 2):3000-8. PubMed ID: 23902153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai.
    Li Q; Hou L; Guo ZH; Ye LY; Yue DQ; Zhu ZY
    Vox Sang; 2009 Aug; 97(2):139-46. PubMed ID: 19490579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of weak D and DEL in Han population in Anhui Province, China.
    Chen Q; Li M; Li M; Lu XS; Lü R; Sun J; Liu Z
    Chin Med J (Engl); 2012 Sep; 125(18):3251-5. PubMed ID: 22964318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outliers in RhD membrane integration are explained by variant RH haplotypes.
    Yu X; Wagner FF; Witter B; Flegel WA
    Transfusion; 2006 Aug; 46(8):1343-51. PubMed ID: 16934070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76.
    Gassner C; Utz I; Schennach H; Ramoni A; Steiner H; Scholz S; Kreklau U; Körmöczi GF
    Transfusion; 2013 Nov; 53(11 Suppl 2):2954-9. PubMed ID: 23550956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
    Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak D type 2 is the most prevalent weak D type in Portugal.
    Araújo F; Rodrigues MJ; Monteiro F; Chabert T; Tavares G; Sousa G; Storry J; Guimarães JE
    Transfus Med; 2006 Feb; 16(1):63-7. PubMed ID: 16480441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.